Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
Since coronavirus disease 2019 (COVID-19) is a serious new worldwide public health crisis with significant morbidity and mortality, effective therapeutic treatments are urgently needed. Drug repurposing is an efficient and cost-effective strategy with minimum risk for identifying novel potential tre...
Saved in:
Main Authors: | Dan-Yang Liu (Author), Jia-Chen Liu (Author), Shuang Liang (Author), Xiang-He Meng (Author), Jonathan Greenbaum (Author), Hong-Mei Xiao (Author), Li-Jun Tan (Author), Hong-Wen Deng (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
by: Shuang Liang, et al.
Published: (2023) -
A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments
by: Xiao-Hua Li, et al.
Published: (2023) -
Network pharmacology and transcriptomics reveal the mechanisms of FFBZL in the treatment of oral squamous cell carcinoma
by: Shiyang Zhao, et al.
Published: (2024) -
Network Pharmacology Integrated with Transcriptomics Analysis Reveals Ermiao Wan Alleviates Atopic Dermatitis via Suppressing MAPK and Activating the EGFR/AKT Signaling
by: Xia T, et al.
Published: (2022) -
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
by: Melissa Alegría-Arcos, et al.
Published: (2022)